Illustration by Radina Dobrinova

How aca­d­e­m­ic cen­ters are try­ing to keep their promis­ing drug dis­cov­er­ies out of the ‘val­ley of death’

Scripps Re­search hatch­es med­i­cines. Now, it’s look­ing to spark some­thing else: a mod­el for fi­nan­cial in­de­pen­dence.

The bio­med­ical in­sti­tute has car­ried pro­grams in­to clin­i­cal tri­als, and else­where, the Uni­ver­si­ty of Texas MD An­der­son Can­cer Cen­ter is co-de­vel­op­ing com­pa­nies.

No longer be­hold­en to ear­ly-stage pacts with phar­ma­ceu­ti­cals, aca­d­e­m­ic cen­ters are try­ing to do a bet­ter job cap­i­tal­iz­ing on their sci­ence. The goal is to ease their re­liance on gov­ern­ment fund­ing and over­come the “val­ley of death” in which promis­ing re­search lan­guish­es.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.